No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
RGNX241220P10000
- 2.60
- +1.10+73.33%
15min DelayClose Dec 20 16:00 ET
2.60High2.60Low
2.60Open1.50Pre Close10 Volume160 Open Interest10.00Strike Price2.60KTurnover0.00%IV2.89%PremiumDec 20, 2024Expiry Date2.38Intrinsic Value100Multiplier-1DDays to Expiry0.22Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.46Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
PepGen Stock Craters 35% on FDA Clinical Hold
RBC Capital Reiterates Outperform on Regenxbio, Maintains $35 Price Target
RBC Capital Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $35
Express News | Regenxbio Inc - to Offer and Sell Shares up to $150 Million
Express News | Regenxbio Inc - on Dec 9, Co Enters Sales Agreement With Leerink Partners
Apollo Global Management, Workday to Join S&P 500